This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Moreno AC, Saggia MG, Santos EA, Rodrigues S.Cost-benefit analysis of oseltamivir versus no antiviral treatment from the employer perspective: the Roche Brazil case. Value in Health 10: 436 (plus oral presentation) abstr. PIN4, No. 6, Nov-Dec 2007
Rights and permissions
About this article
Cite this article
Oseltamivir cost saving for influenza in Brazil. Pharmacoecon. Outcomes News 540, 6 (2007). https://doi.org/10.2165/00151234-200705400-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705400-00008